Grace Therapeutics Reports Q2 FY2027 Earnings: $2.1 Million Net Loss and $1. ...
Cash Position Strengthened to $21.3 Million After $10 Million Private Placement as GTx-104 NDA Resubmission Work Continues Related Stocks: GRCE ,
Cash Position Strengthened to $21.3 Million After $10 Million Private Placement as GTx-104 NDA Resubmission Work Continues Related Stocks: GRCE ,